CAS 303957-69-9

Fórmula: C20H31NO4

InChI: InChI=1S/C20H31NO4/c1-5-6-7-8-9-10-11-12-17(23)21-16(13-14(2)3)19(24)18(15(4)22)20(21)25/h11-12,14,16,24H,5-10,13H2,1-4H3/b12-11+/t16-/m1/s1

Chave InChI: GNGSBVNLHSNSDF-LPQFERQCSA-N

SMILES: CCCCCCC/C=C/C(=O)N1[C@@H](C(=C(C1=O)C(=O)C)O)CC(C)C

Reutericyclin

CAS: 303957-69-9

Reutericyclin

Peso molecular: 349.23

Ref: 10-F557022

Reutericyclin

CAS: 303957-69-9

Reutericyclin

Fórmula: C₂₀H₃₁NO₄

Pureza: 95.15%

Peso molecular: 349.46

Ref: 54-OR1114999

Reutericyclin

CAS: 303957-69-9

Reutericyclin is an oral anti-Gram-positive compound with antibacterial and anti-obesity effects regulating intestinal flora.

Fórmula: C₂₀H₃₁NO₄

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 349.4644

Ref: TM-T12712

Reutericyclin

CAS: 303957-69-9

Fórmula: C₂₀H₃₁NO₄

Pureza: 95.15%

Peso molecular: 349.4644

Ref: IN-DA00BJH7

Reutericyclin

CAS: 303957-69-9

Reutericyclin is a novel antibiotic that inhibits fatty acid synthesis. It has been shown to be effective against oral pathogens and microbial infections. Reutericyclin has been shown to inhibit the growth of bacteria by binding to the bacterial fatty acid synthase, which is an enzyme that catalyzes the first step in the biosynthesis of fatty acids. The drug also binds to ATP synthase, preventing the production of ATP, which is needed for bacterial cell division. Reutericyclin has been shown to have antimicrobial properties in both model systems and humans, but it does not have any significant side effects on humans or animals.

Fórmula: C₂₀H₃₁NO₄

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 349.5 g/mol

Ref: 3D-DMA95769